Houman Khalili
Overview
Explore the profile of Houman Khalili including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
1263
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neupane G, Sharma R, Parajuli R, Mathews A, Khalili H
CJC Open
. 2024 Nov;
6(11):1259-1273.
PMID: 39582698
Background: Cardiac papillary fibroelastomas (CPFs) are benign endocardial tumours with embolic potential. This article is a systematic review to identify the clinical profile, diagnosis, tumour characteristics, and treatment modalities in...
2.
3.
Eng M, Khalili H, Abbas A
JACC Cardiovasc Interv
. 2024 Nov;
17(21):2570.
PMID: 39537280
No abstract available.
4.
Eng M, Khalili H, Vavalle J, Al-Azizi K, Waggoner T, Southard J, et al.
JACC Cardiovasc Interv
. 2024 Aug;
17(17):2041-2051.
PMID: 39177555
Background: A prior Society of Thoracic Surgeons/American College of Cardiology TVT (Transcatheter Valve Therapy) Registry-based analysis reported similar 1-year clinical outcomes with small (20-mm) vs large (≥23-mm) balloon-expandable valves (BEV)....
5.
Madanat L, Jabri A, Hanson I, Khalili H, Rodes-Cabau J, Pilgrim T, et al.
Curr Cardiol Rep
. 2024 Jul;
26(9):1005-1009.
PMID: 39073506
Background: Obesity paradox in cardiovascular risk prediction has gained increasing attention in recent years. We aimed to investigate the impact of BMI on mortality following transcatheter aortic valve replacement (TAVR)....
6.
Abbas A, Khalili H
JACC Cardiovasc Interv
. 2024 Jun;
17(12):1509.
PMID: 38925754
No abstract available.
7.
Abbas A, Madanat L, Khalili H, Mando R, Kheyrbek M, Chandra R, et al.
Am J Cardiol
. 2024 Apr;
220:49-55.
PMID: 38580038
On July 31, 2023, the Trifecta valve was withdrawn from the market after concerns regarding early (≤5 years) structural valve deterioration (SVD), mainly as aortic regurgitation (AR). Our aim was...
8.
Shaukat S, Lodhi H, Khan H, Desai A, Luna M, Brilakis E, et al.
J Invasive Cardiol
. 2024 Jan;
36(1).
PMID: 38224297
Objectives: Guide catheter extensions (GCEs) are commonly used to facilitate percutaneous coronary interventions (PCIs). We investigated the incidence and modes of failure of GCEs.. Methods: Data from the Manufacturer and...
9.
Madanat L, Allam M, Khalili H, Rabah A, Tariq R, Zamzam M, et al.
Am J Cardiol
. 2023 Dec;
213:140-145.
PMID: 38134979
Transcatheter aortic valve replacement (TAVR) has emerged as a successful treatment option for severe aortic stenosis. However, the long-term outcomes of TAVR in nonagenarians is lacking. We aimed to examine...
10.
Lodhi H, Shaukat S, Mathews A, Maini B, Khalili H
Am J Cardiol
. 2023 Oct;
209:181-183.
PMID: 37863115
Suture-mediated closure device and Figure-of-Eight suture are commonly used to achieve hemostasis after use of large bore venous access. Although both methods of closure are commonly used in clinical practice,...